TY - JOUR
T1 - Multiparametric magnetic resonance imaging for radiotherapy response evaluation in high-risk soft tissue sarcoma
T2 - A pilot study
AU - van Meekeren, Milan
AU - van Houdt, Petra J.
AU - Fiocco, Marta
AU - Winfield, Jessica M.
AU - Messiou, Christina
AU - Heeres, Birthe C.
AU - Gelderblom, Hans
AU - Steeghs, Neeltje
AU - Haas, Rick
AU - van Langevelde, Kirsten
N1 - © 2025 The Authors.
PY - 2025/7
Y1 - 2025/7
N2 - Background and purpose: Soft tissue sarcomas (STS) are rare mesenchymal tumors for which no clinically validated quantitative magnetic resonance imaging (qMRI) parameters exist yet. This study explores repeatability and association with histopathology of qMRI parameters during and after neo-adjuvant angiogenesis inhibition (oral pazopanib) and radiotherapy for localized, high-risk STS. Materials and methods: For fifteen patients, qMRI parameters, including apparent diffusion coefficient (ADC), volume transfer constant (Ktrans) and T2 relaxation times were acquired twice at baseline (B1 and B2), twice during neo-adjuvant treatment and pre-surgery. For all three parameters, the mean was determined per tumor. Subsequently, repeatability coefficient (RC or %RC) was assessed from B1 and B2 mean values. Mixed models were estimated to study the association between percentage viable cells from histopathology and absolute change from baseline (ΔqMRI) for ADC mean and percentage change from baseline (%ΔqMRI) for T2 and Ktrans at each time point. Results: RC was 0.17 × 10-3 mm2/s for ADC and %RC was, 5 % and 65 % for T2 and Ktrans, respectively. The changes in mean ADC and T2 showed both increases and decreases at each timepoint, whereas mean Ktrans predominantly showed decreases. ΔqMRI for ADC mean, %ΔqMRI for T2 mean and %ΔqMRI for Ktrans mean showed no statistically significant association with % viable cells. Conclusion: This pilot study reported relatively low repeatability coefficients for ADC and T2 and a higher repeatability coefficient for Ktrans and showed heterogeneous changes in qMRI parameters in fifteen STS patients, however with no association between these parameters and percentage viable cells.
AB - Background and purpose: Soft tissue sarcomas (STS) are rare mesenchymal tumors for which no clinically validated quantitative magnetic resonance imaging (qMRI) parameters exist yet. This study explores repeatability and association with histopathology of qMRI parameters during and after neo-adjuvant angiogenesis inhibition (oral pazopanib) and radiotherapy for localized, high-risk STS. Materials and methods: For fifteen patients, qMRI parameters, including apparent diffusion coefficient (ADC), volume transfer constant (Ktrans) and T2 relaxation times were acquired twice at baseline (B1 and B2), twice during neo-adjuvant treatment and pre-surgery. For all three parameters, the mean was determined per tumor. Subsequently, repeatability coefficient (RC or %RC) was assessed from B1 and B2 mean values. Mixed models were estimated to study the association between percentage viable cells from histopathology and absolute change from baseline (ΔqMRI) for ADC mean and percentage change from baseline (%ΔqMRI) for T2 and Ktrans at each time point. Results: RC was 0.17 × 10-3 mm2/s for ADC and %RC was, 5 % and 65 % for T2 and Ktrans, respectively. The changes in mean ADC and T2 showed both increases and decreases at each timepoint, whereas mean Ktrans predominantly showed decreases. ΔqMRI for ADC mean, %ΔqMRI for T2 mean and %ΔqMRI for Ktrans mean showed no statistically significant association with % viable cells. Conclusion: This pilot study reported relatively low repeatability coefficients for ADC and T2 and a higher repeatability coefficient for Ktrans and showed heterogeneous changes in qMRI parameters in fifteen STS patients, however with no association between these parameters and percentage viable cells.
KW - Magnetic resonance imaging
KW - Radiotherapy
KW - Repeatability
KW - Soft tissue sarcoma
KW - Treatment response evaluation
UR - https://www.scopus.com/pages/publications/105012314027
UR - https://www.mendeley.com/catalogue/818efd54-3f04-38e4-87c3-25130bec39c9/
U2 - 10.1016/j.phro.2025.100818
DO - 10.1016/j.phro.2025.100818
M3 - Article
C2 - 40809786
AN - SCOPUS:105012314027
SN - 2405-6316
VL - 35
JO - Physics and Imaging in Radiation Oncology
JF - Physics and Imaging in Radiation Oncology
M1 - 100818
ER -